Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
3D Medicines, Inc. ( (HK:1244) ) has issued an announcement.
3D Medicines Inc. has announced a strategic cooperation agreement with Qingdao Hainuo, aimed at resolving ongoing legal disputes and fostering future collaboration. The agreement, valued at RMB98.0 million, led to the withdrawal of civil proceedings and the discharge of a Preservation Order, thereby enhancing the company’s operational and financial stability.
More about 3D Medicines, Inc.
Average Trading Volume: 247,060
Technical Sentiment Signal: Buy
Current Market Cap: HK$1.3B
See more data about 1244 stock on TipRanks’ Stock Analysis page.